ArticleFrontiers in cardiovascular medicine2025
Non-fluoroscopic vs. fluoroscopic radiofrequency catheter ablation for pediatric atrioventricular nodal reentrant tachycardia: a comparative study of procedural characteristics and ablation site.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Zero Fluoroscopy Radiofrequency Slow-Pathway Modification for AVNRT in Patients ≤ 21 Years: A Single-Center Cohort and Contextual Review of Literature.Journal of arrhythmia · 2026Article
- Zero- or minimal-fluoroscopy vs conventional fluoroscopy in catheter ablation of supraventricular tachycardias: An updated systematic review and meta-analysis.Heart rhythm O2 · 2026Article
- Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Article
- Editorial: New advances in cardiac electrophysiology.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-fluoroscopic cryoablation is considered safe for pediatric atrioventricular nodal reentrant tachycardia (AVNRT), but concerns about prolonged procedures and recurrence persist, requiring continued use of radiofrequency ablation (RFA). Non-fluoroscopic RFA, guided by three-dimensional mapping, offers enhanced precision. This study compares its safety and effectiveness with fluoroscopic RFA in pediatric AVNRT. Methods: We retrospectively analyzed children undergoing RFA without (X- group) or with (X+ group) fluoroscopy at multiple centers (2011-2024). Patients who received fluoroscopic and three-dimensional mapping guidance were excluded. Baseline characteristics, electrophysiological data, and ablation outcomes were compared. Results: Among 119 patients (X+, 57; X-, 62), there was a significantly higher rate of successful ablation sites in the lower Koch triangle on 3D electroanatomical mapping (3D-EAM). However, the procedure time, acute success rate, recurrence-free survival of AVNRT, and injury to the conduction system were similar between the groups. No permanent complete atrioventricular block was observed in either group. The longer procedure time was independently correlated with ablation location outside of the low Koch triangle, lower common pathway block, and slow pathway modification. Dual AV nodes without inducible tachycardia had lower AVNRT-free survival than typical and atypical AVNRT (80% vs. 96.5% vs. 100%, Conclusions: Non-fluoroscopic RFA, guided by 3D-EAM, achieves comparable acute and mid-term outcomes to fluoroscopic RFA in pediatric AVNRT. The successful site of slow pathway ablation was significantly lower when using 3D-EAM compared with fluoroscopy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.